Oral Appliances and Medical Management for Sleep Apnea and Temporomandibular Joint Disease
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage, coding, and clinical stance for intraoral oral appliances and novel non‑PAP treatments for obstructive sleep apnea (OSA) and states noncoverage for appliances for TMJ/bruxism and certain novel devices; applies to Medicare Advantage and commercial products of the payer.
No material clinical or coverage changes in this revision.
Coverage determinations and exclusions
Coverage and noncoverage
Coverage determinations summarized:
Medicare Advantage and Commercial Products; provider must be trained in oral sleep appliances
Medicare Advantage and Commercial Products
Billing details; member financial responsibility applies for copays/coinsurance/deductibles
The policy explicitly excludes certain devices and indications from coverage. Oral appliances used to treat temporomandibular joint disease (TMJ) or bruxism and devices intended for snoring not associated with sleep apnea are non‑covered for all product lines. Over‑the‑counter oral appliances for OSA are not covered. Specific HCPCS/brand categories identified as not covered or not medically necessary include positional treatment and neuromuscular stimulation codes K1001, K1028, K1029, and interfaces for oral pressure therapy such as A7047. Covered oral appliance HCPCS codes for treatment of documented mild to moderate OSA are E0485 (prefabricated, includes fitting and adjustment) and E0486 (custom fabricated, includes fitting and adjustment).
When services are determined to be not medically necessary or are non‑covered benefits, providers may not charge the member for those services unless the member has been informed and has provided prior written agreement to assume financial responsibility. Benefits and eligibility are governed by the member's subscriber agreement or employer agreement; providers should verify member‑specific benefits via the provider call center before rendering services that may be non‑covered. This policy is informational and does not guarantee payment.
Novel or alternative OSA treatments are considered to have insufficient evidence for net health benefit and are listed as not covered or not medically necessary for Medicare Advantage and Commercial Products. These include palate and mandible expansion devices, nasal expiratory positive airway pressure (EPAP), oral pressure therapy (OPT), daytime electrical/tongue stimulation devices, and sleep positioning trainers with supine vibration. The evidence base comprises small series, single‑arm studies, and limited randomized trials with inconsistent results, high drop‑out rates, and uncertain long‑term compliance, and therefore additional well‑designed trials are needed.
If a device or service is non‑covered, providers must confirm member benefits before initiating treatment and obtain written agreement from the member if the member will be responsible for charges. For services without specific CPT/HCPCS codes, claims should be filed with the unlisted DME code as noted. When billing for oral appliances that are covered, use the applicable HCPCS (E0485, E0486); do not bill covered appliance services separately for components included in the global fee (initial evaluation, impressions, fabrication, initial fitting/education, and up to three follow‑up visits are considered inclusive). Replacement and repairs follow Durable Medical Equipment repair/replacement provisions and do not require prior authorization per policy guidance, but providers should still verify member‑specific rules.
Billing codes and status
| K1001 | Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type |
| K1028 | Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle for the reduction of snoring and obstructive sleep apnea, controlled by phone application |
| K1029 | Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply |
| A7047 | Oral interface used with respiratory suction pump, each |
| unlisted DME | Use for services/therapies without assigned CPT/HCPCS codes (e.g., prior to specific code availability) |
| 95807-52 | Daytime, abbreviated cardio-respiratory sleep study (referenced CPT code in literature) |
What providers must do
Prior Authorization
Prior authorization review is not required.
Repairs and Replacements
Replacement appliances and repairs are covered as medically necessary per the Durable Medical Equipment Repair and Replacement policy. Medical review/preauthorization is not required for repairs or replacements because initial services do not require prior authorization.
- Repairs/Replacements follow DME Repair & Replacement policy
- No preauthorization required for repairs/replacements
Verify Benefits, Eligibility, and LCDs
Verify member benefits and eligibility before providing services. Coverage is determined by the member's subscriber certificate/employer agreement and may vary by product. Consult the provider call center or eligibility files for member‑specific information. Also consult applicable CMS Local Coverage Determinations (e.g., LCD L33611 and Policy Article A52512) for Medicare Advantage members.
- Check member-specific benefits and eligibility
- Consult CMS LCDs for Medicare Advantage coverage rules
Included Services and Billable Diagnostics
The following services associated with a custom oral appliance are considered included in the global fee for the device and should not be billed separately except as noted: initial evaluation (or appropriate E/M if not a candidate), oral/dental impressions, fabrication, initial fitting and patient education, and three follow-up visits after device initiation. A set of cephalometric X‑rays (with and without the appliance) may be billed separately as diagnostic testing.
- Included in global device fee: initial evaluation, impressions, fabrication, initial fitting/education, three follow-up visits
- Cephalometric X‑rays (with/without appliance) billable separately
- Additional visits beyond the three follow-ups are member responsibility unless a new device is supplied
Therapy Sequencing
Clinical sequencing: CPAP is supported as first‑line therapy for obstructive sleep apnea. Oral appliances are appropriate for documented mild‑to‑moderate OSA or for patients who cannot tolerate CPAP, when clinical criteria are met and documented. There is no required waiting period to obtain an oral appliance when a member has a CPAP.
- CPAP = first‑line therapy
- Oral appliances = option for documented mild‑to‑moderate OSA or CPAP intolerance
- No waiting period for oral appliance when member has CPAP
Alternative Therapy Considerations
Alternative and adjunctive therapies (e.g., nasal EPAP devices, positional therapy, daytime neuromuscular electrical stimulation of the tongue, palate/mandible expansion devices, nasal expiratory positive airway pressure, and oral pressure therapy) have limited or mixed evidence. Some of these are considered not covered or not medically necessary due to insufficient evidence. Consider these options only as adjuncts or investigational alternatives and document rationale and prior treatment attempts.
- EPAP, oral pressure therapy, daytime tongue electrical stimulation, palate/mandible expansion — evidence insufficient; often not covered
- Positional therapy and sleep position trainers — studied as adjuncts; review evidence and document clinical rationale
- If using alternative devices, document prior therapies tried (e.g., CPAP) and medical necessity
Background, scope, and definitions
Obstructive sleep apnea (OSA) is characterized by recurrent upper airway collapse during sleep leading to intermittent hypoxemia, arousals, daytime sleepiness, and potential cardiopulmonary consequences. Management strategies include weight loss and positional measures, with continuous positive airway pressure (CPAP) supported as first‑line therapy. Oral appliances (mandibular advancing/positioning or tongue‑retaining devices), when custom fitted and rendered by trained providers, are an evidence‑based option for documented mild to moderate OSA. Novel therapies (EPAP, OPT, tongue stimulation, palate expansion, positional vibration) currently lack sufficient evidence to demonstrate improved net health outcomes and therefore are not covered or are considered not medically necessary.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.